AER under FFDCA sec. 760 - nonprescription drug products

Postmarketing Adverse Drug Experience Reporting

0636 GFI on AER for NonRx Human Drug Products

AER under FFDCA sec. 760 - nonprescription drug products

OMB: 0910-0230

Document [file]
Download: file | pdf
File Typeinode/x-empty

© 2024 OMB.report | Privacy Policy